It's OK To Let People Take Risks for Medical Science
A recent study finds that human challenge trials are largely safe.
A recent study finds that human challenge trials are largely safe.
Eliminating taxation on compensation for being a human guinea pig is just good public policy.
The omicron COVID-19 variant is likely to sweep through the country in the next month or so.
It's a good idea, but it should have been done much earlier.
But masks are still likely to prevent infected people from transmitting the virus.
Safe and effective vaccines by the end of this year?
The antimalarial drug is being removed from United Kingdom's RECOVERY trial evaluating COVID-19 therapies.
The observational dataset on which it was based could not be properly audited.
A major study in The Lancet said it doesn't—but it may have relied on fabricated data.
The World Health Organization pauses clinical trials in light of disturbing new results.
Volunteers would earn cash for the risks they take on our behalf.
Promising randomized controlled trial results indicate the drug shortens time to recovery
A contrast with last week's leaked results from a University of Chicago study
STAT reports leaked comments of University of Chicago researcher
"The best available evidence does not support the use of hydroxychloroquine in COVID-19."
An idea that could really speed up vaccine development
FDA is reportedly cutting red tape to give expanded access to COVID-19 patients.
MDMA, which was banned by the Drug Enforcement Administration in 1985, could be available by prescription as soon as 2021.
Slashing the restraints on the agency's slow and burdensome process.
What happens when cancer doctors, psychologists, and drug developers can't rely on each other's research?
"Right to try" laws offer hope for people trying to save their own lives.